Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, September 29, 2020
Thomas H. Lee Partners and Frazier Healthcare have acquired Adare, which will be rebranded Adare Pharma Solutions, a specialty CDMO and provider of advanced pharmaceutical technologies, from TPG Capital.
read more
Tuesday, January 15, 2019
Quanticate has launched QVigilance to provide dedicated pharmacovigilance (PV) and risk management services.
read more
Thursday, December 05, 2019
Italy-based Stevanato Group has broken ground on a new Technology Excellence Center in Boston.
read more
Catalent will provide development, manufacturing and commercialization services for lenzilumab, Humanigen’s anti-human GM-CSF monoclonal antibody.
read more
Friday, November 01, 2019
Atlanta is now Dachser's fourth location to receive certification in ten months, further expanding the company's network services for its customers in the life science and healthcare sector.
read more
Thursday, December 20, 2012
Marken is hosting an open house in January for their new GMP-compliant depot located in Farmingdale, New York. During the grand opening celebration and depot tour, Marken will also facilitate a round table to address key issues related to clinical ...
read more
Monday, November 30, 2020
Allos Pharma has announced the exclusive license rights on arbaclofen in Fragile X Syndrome.
read more
Intravacc, has been awarded a contract with base and options that may total US$14.6 million from the US National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), for the development of a ...
read more
Heptares Therapeutics announced the launch of a new research collaboration under its ORBIT initiative with New York University School of Medicine.
read more
Thursday, February 04, 2016
AMRI has announced that Anthony J. Maddaluna, Executive Vice President of Pfizer Inc. and President of Pfizer Global Supply, has been elected to the AMRI Board of Directors, effective as of February 4, 2016.
read more
Avista Pharma Solutions, Inc. has initiated a significant expansion and enhancement of its contract testing facility in Agawam, Mass.
read more
Wednesday, August 03, 2016
Velocity Fund Partners, a Pittsburgh private equity company, has announced the acquisition of the Philadelphia clinical contract research organization (CRO) Indipharm and is relaunching the CRO as InClinica. Financial terms were not disclosed.
read more
Advarra has completed all integration activities.
read more
Patheon, a global provider of pharmaceutical development and manufacturing services announced that Michel Lagarde has been appointed as its President, effective immediately. In this newly created role, Lagarde will lead global corporate and cross-...
read more
Monday, September 19, 2016
Jubilant Biosys Ltd has announced two new leadership appointments. Mr. Steven Hutchins has been appointed as President and Dr. Takeshi Yura has been appointed as Vice President of Medicinal Chemistry.
read more